Choudhury Monisha, Nangia Anita, Singh Sanjeet Kumar, Pujani Mukta, Thomas Shaji
Department of Pathology, Lady Hardinge Medical College and Shrimati Sucheta Kriplani Hospital, New Delhi-1 10001, India.
Acta Cytol. 2010 Sep-Oct;54(5 Suppl):985-8.
Malignant mesenchymal tumors constitute < 1% of all malignant neoplasms of the breast. These include pure primary sarcoma of the breast, metastatic sarcoma and sarcomatous patterns in metaplastic carcinomas. On fine needle aspiration cytology (FNAC), the cellular features can suggest the diagnosis of sarcoma of the breast, although the potential exists for confusion with very poorly differentiated carcinoma.
A case of recurrent primary malignant fibrous histiocytoma (MFH) occurred in the breast in a 32-year-old woman. The patient presented with a fungating mass in the right breast. FNAC was suggestive of malignant mesenchymal tumor, most probably MFH. The diagnosis was confirmed on biopsy.
Malignant fibrous histiocytoma of the breast is a rare entity, and a complete clinicopathologic correlation with immunohistochemical profile is essential to arrive at a correct diagnosis and guide appropriate management of the patient.
恶性间叶性肿瘤占所有乳腺恶性肿瘤的比例不到1%。这些包括乳腺原发性单纯肉瘤、转移性肉瘤以及化生性癌中的肉瘤样形态。在细针穿刺细胞学检查(FNAC)中,细胞特征可提示乳腺肉瘤的诊断,尽管存在与分化极差的癌混淆的可能性。
一名32岁女性乳腺出现复发性原发性恶性纤维组织细胞瘤(MFH)。患者右乳出现一个溃疡性肿块。FNAC提示为恶性间叶性肿瘤,很可能是MFH。活检确诊了该诊断。
乳腺恶性纤维组织细胞瘤是一种罕见疾病,完整的临床病理相关性及免疫组化特征对于做出正确诊断并指导患者的恰当治疗至关重要。